经尼莫利祖马布 (Nemolizumab) 给药后,严重的无氧性皮肤炎与日间睡眠增加:一个病例报告
Kenta Horimukai1, Misako Kinoshita1, Noriko Takahata1
1Department of Pediatrics, Jikei University Katsushika Medical Center, Katsushika, JPN.
Cureus
|March 3, 2025
概括
尼莫利祖马布有效治疗严重的亚托皮炎 (AD) 并减少. 然而,这种介素-31受体α抑制剂在一名患者中引起了显著的白天嗜睡,突显了需要仔细监测的需要.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 亚托皮炎 (AD) 由于严重的和睡眠障碍,显著影响生活质量.
- 目前治疗严重阿尔茨海默病的方法往往不够,需要新的治疗方法.
研究的目的:
- 报告一个用因特鲁金-31受体α抑制剂尼莫利祖马布治疗的严重AD病例.
- 调查纳莫利祖马布在耐火性AD病例中的疗效和潜在副作用.
主要方法:
- 一名16岁的男性患有严重的治疗不耐药的阿尔茨海默症,接受了皮下纳莫利祖马布.
- 使用湿疹区域和严重性指数 (EASI),患者导向湿疹测量 (POEM) 和亚托皮炎控制工具 (ADCT) 评分来评估有效性.
- 使用爱普沃思睡眠度量 (ESS) 评估了睡眠度.
主要成果:
- 尼莫利祖马布治疗导致了EASI,POEM和ADCT得分的显著改善.
- 患者在每次注射后经历了明显的白天嗜睡和ESS得分增加.
- 停用尼莫利祖马布治疗解决了高睡眠症,而皮肤病的改善仍然存在.
结论:
- 尼莫利祖马布在治疗严重的亚托皮性皮炎方面表现出有效性.
- 悖论性超眠症是尼莫利祖马布的潜在副作用,可能与IL-31抑制途径有关.
- 对于接受尼莫利祖马布的患者来说,密切监测皮肤病状况和白天警觉度至关重要.
相关概念视频
Narcolepsy
85
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
85
Sedatives and Hypnotics Drugs: Miscellaneous Agents
143
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
143
Management of Insomnia
229
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
229
REM Sleep Behavior Disorder
127
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
127
Insufficient Sleep and Sleep Deprivation
125
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
125
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
222
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
222


